Rifampin and Topamax drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rifampin (rifampin) and Topamax (topiramate). Common drug interactions include dermatitis among females and abdominal pain among males.
The phase IV clinical study analyzes what interactions people have when they take Rifampin and Topamax. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Rifampin?
Rifampin has active ingredients of rifampin. It is often used in tuberculosis. eHealthMe is studying from 12,339 Rifampin users. Check the latest studies of Rifampin.
What is Topamax?
Topamax has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 58,954 Topamax users. Check the latest studies of Topamax.
29 people who take Rifampin and Topamax together, and have interactions are studied.

What are the common drug interactions of Rifampin and Topamax, by gender? *:
female:
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Diabetes mellitus inadequate control
- Diabetic gastropathy (gastric neuromuscular dysfunction in diabetes mellitus)
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
- Diarrhoea
- Disability
- Disease recurrence
- Disturbance in attention
- Drug dependence
male:
- Abdominal pain
- Cardiac disorder
- Pain
- Pain in extremity
- Procedural site reaction
- Pulmonary embolism (blockage of the main artery of the lung)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Subcutaneous abscess
- Subcutaneous haematoma (collection of blood outside the blood vessels on the skin)
- Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
What are the common drug interactions of Rifampin and Topamax, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Papillary thyroid cancer
- Suicidal ideation
- Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
30-39:
- Abdominal discomfort
- Abdominal pain
- Anxiety
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Hypotension (abnormally low blood pressure)
- Memory impairment
- Suicidal ideation
40-49:
- Chronic kidney disease
- Nasal obstruction (blockage of nose)
- Pneumonia
- Renal failure (kidney dysfunction)
50-59:
- Contusion (a type of hematoma of tissue in which capillaries)
- Dyspepsia (indigestion)
- Renal failure (kidney dysfunction)
- Renal injury (kidney injury)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Disease recurrence
- Limb injury
- Renal failure acute (rapid kidney dysfunction)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Road traffic accident
60+:
- Drug hypersensitivity
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 55.17%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 20.69%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.79%
- High Blood Pressure: 3 people, 10.34%
- High Blood Cholesterol: 3 people, 10.34%
- Type 2 Diabetes: 2 people, 6.90%
- Stress And Anxiety: 2 people, 6.90%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 6.90%
- Pain: 2 people, 6.90%
- Oedema (fluid collection in tissue): 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Rifampin and Topamax?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Rifampin and Topamax:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rifampin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Topamax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rifampin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Topamax and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
- Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on rifampin and topiramate (the active ingredients of Rifampin and Topamax, respectively), and Rifampin and Topamax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Valproic Acid and Temazepam - 2 seconds ago
- Could Furosemide cause West Nile Viral Infection? - 3 seconds ago
- Could Bupropion Hydrochloride cause Taste - Impaired? - 13 seconds ago
- Could Cymbalta cause Appetite - Decreased? - 15 seconds ago
- Could Cymbalta cause Appetite Decreased? - 15 seconds ago
- Drug interactions of Calcium Carbonate and Demerol - 22 seconds ago
- Could Imitrex cause Onychalgia? - 22 seconds ago
- Drug interactions of Micafungin and Bactrim Ds - 33 seconds ago
- Could Perindopril Erbumine cause Osteoarthritis Aggravated? - 34 seconds ago
- Lipidil vs. Zetia, side effect and effectiveness comparison - 37 seconds ago